A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

A novel drug molecule could potentially lead to new treatments to prevent Parkinson's disease in younger patients, according to new research.

Exercise is known as one of the best weapons in limiting the effects of the disease and creating dopamine that is low for ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

Increased exposure to air pollution in the form of particulate matter with a diameter of 2.5 µm or less (PM2.5) and nitrogen ...

It could be a medical condition called essential tremor, and a new study by Singapore’s National Neuroscience Institute has ...

But these drugs might also protect brain health, researchers found. SGLT2 inhibitors are associated with a 20% reduced risk of Alzheimer's disease or Parkinson's disease, and a 30% reduced risk of ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...